Concrete Failures Spur Urgent Trials for Eden’s Pz7 in India’s Infrastructure Push

Eden Innovations advances trials of its EdenCrete® Pz7 concrete admixture in India, targeting improved durability in government infrastructure projects amid a push for sustainable highway construction.

  • Ongoing EdenCrete® Pz7 trials with Indian Central Road Research Institute
  • Testing on M60 and M40 concrete grades for highways and pavements
  • India’s National Highway network expanded 60% since 2014
  • Government focus shifting to technology and sustainability in road building
  • Potential for significant sales growth if trials prove successful
An image related to Eden Innovations Ltd
Image source middle. ©

Eden Innovations Advances EdenCrete® Pz7 Trials in India

Eden Innovations Ltd (ASX – EDE) has provided an encouraging update on its EdenCrete® Pz7 concrete admixture trials in India, conducted in partnership with the Central Road Research Institute (CRRI). The trials focus on enhancing the performance of two key concrete grades widely used in Indian government infrastructure projects – M60 and M40. These grades are critical for bridge overlays, ultra-thin white topping repairs, and new road pavements.

India’s infrastructure landscape is rapidly evolving, with the National Highway network having expanded by 60% over the past decade to become the world’s second largest. This growth has been accompanied by challenges, including premature failures in concrete pavements that prompted a Public Accounts Committee enquiry in 2025. The government is now prioritising the integration of advanced technology and sustainability measures in highway construction to address these issues.

Targeting Concrete Durability and Sustainability

The current EdenCrete® Pz7 trials aim to improve the flexural strength and abrasion resistance of M60 grade concrete, which is used for bridge overlays and ultra-thin white topping (UTWT) applications. UTWT involves placing a thin concrete layer over existing pavements to extend their lifespan, a technique gaining traction as a repair solution. Simultaneously, trials on M40 pavement quality concrete (PQC) could open doors to broader adoption in new road construction.

One promising avenue is the Maharashtra State Infrastructure Development Corporation’s (MSIDC) upcoming projects, with an estimated budget exceeding AUD 6 billion. These projects require contractors to maintain roads for 15 years post-completion, underscoring the demand for durable materials. Positive trial outcomes could position EdenCrete® Pz7 as a preferred additive in these large-scale developments.

Market Outlook and Government Priorities

India’s Ministry of Road Transport and Highways has allocated over AUD 45 billion for road infrastructure in the current financial year, targeting the construction of 10,000 kilometres of new highways. The government’s renewed focus on quality and sustainability, following the Public Accounts Committee’s findings on concrete road failures, aligns well with Eden’s product proposition.

While the trials are ongoing and results are pending, Eden Innovations expresses cautious optimism. The preliminary trials showed promising improvements, justifying the expanded testing phase. Should the trials confirm performance gains, EdenCrete® Pz7 could see significant uptake across India’s vast and growing infrastructure market.

For Eden Innovations, India represents a critical growth frontier. The combination of a massive infrastructure budget, government emphasis on durability and sustainability, and the scale of road construction projects creates a fertile environment for EdenCrete® Pz7’s commercial success.

Bottom Line?

Eden’s upcoming trial results could unlock a major growth chapter amid India’s infrastructure transformation.

Questions in the middle?

  • Will EdenCrete® Pz7 meet the durability benchmarks required by Indian infrastructure authorities?
  • How quickly could Eden Innovations scale production and distribution if trials succeed?
  • What impact will government procurement policies have on EdenCrete® adoption?